Skandinaviska Enskilda Banken AB publ lifted its stake in Envision Healthcare Co. (NYSE:EVHC) by 30.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,229 shares of the company’s stock after buying an additional 4,700 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Envision Healthcare were worth $909,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its holdings in Envision Healthcare by 21.6% in the third quarter. Dimensional Fund Advisors LP now owns 1,986,612 shares of the company’s stock valued at $89,289,000 after purchasing an additional 352,654 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in Envision Healthcare by 6.7% in the third quarter. Schwab Charles Investment Management Inc. now owns 674,538 shares of the company’s stock valued at $30,321,000 after purchasing an additional 42,343 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Envision Healthcare by 11.2% in the third quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after purchasing an additional 92,339 shares during the last quarter. Achmea Investment Management B.V. boosted its holdings in Envision Healthcare by 433.8% in the third quarter. Achmea Investment Management B.V. now owns 16,226 shares of the company’s stock valued at $729,000 after purchasing an additional 13,186 shares during the last quarter. Finally, Pegasus Partners Ltd. boosted its holdings in Envision Healthcare by 51.7% in the third quarter. Pegasus Partners Ltd. now owns 80,646 shares of the company’s stock valued at $3,625,000 after purchasing an additional 27,473 shares during the last quarter.
Shares of Envision Healthcare Co. (NYSE:EVHC) traded up $0.67 during trading on Friday, hitting $31.20. The stock had a trading volume of 2,295,800 shares, compared to its average volume of 2,240,959. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. The firm has a market cap of $3,690.75, a PE ratio of 9.42, a price-to-earnings-growth ratio of 0.79 and a beta of 0.57. Envision Healthcare Co. has a fifty-two week low of $23.77 and a fifty-two week high of $73.00.
Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The firm’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.13 earnings per share. research analysts forecast that Envision Healthcare Co. will post 2.57 EPS for the current year.
Envision Healthcare announced that its board has approved a stock repurchase plan on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
A number of research analysts recently commented on EVHC shares. Robert W. Baird reissued a “buy” rating and issued a $70.00 price target on shares of Envision Healthcare in a report on Tuesday, October 17th. SunTrust Banks set a $55.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research note on Sunday, October 15th. Bank of America cut their price objective on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Jefferies Group set a $71.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research note on Thursday, August 24th. Finally, KeyCorp set a $67.00 price objective on Envision Healthcare and gave the company a “buy” rating in a research note on Wednesday, November 1st. One research analyst has rated the stock with a sell rating, six have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $47.57.
COPYRIGHT VIOLATION WARNING: This article was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/08/skandinaviska-enskilda-banken-ab-publ-has-909000-stake-in-envision-healthcare-co-evhc.html.
Envision Healthcare Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.